The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
Walgreens will stock the Auvi-Q as an EpiPen shortage has left some pharmacies unable to fill prescriptions of the lifesaving allergy treatment, leaving some parents scrambling.
Like EpiPen, the Auvi-Q delivers epinephrine to treat severe allergic reactions. The small rectangular auto-injector walks people through its use. Drugmaker Kaleo's partnership with Walgreens will be the first time the Auvi-Q has been available at retail pharmacies. Currently, patients can only receive the devices through the mail.
The Auvi-Q's introduction to Walgreens comes as manufacturing disruptions have led to an EpiPen shortage. Drugstores across the country have no or very few EpiPens in stock. It's especially frustrating for parents who are trying to stock up and send their children back to school with a fresh supply of medication.
Auvi-Q's list price is $4,500 for two auto-injectors. Kaleo, a privately held company, said eligible patients with commercial insurance, even those with high deductible plans or whose insurers don't cover the Auvi-Q, can obtain it at no cost.
People without insurance whose household income is less than $100,000 can get the Auvi-Q for free through an assistance program.
"We are working with insurance providers to maximize coverage of AUVI-Q for as many patients as possible," Phil Rackliffe, general manager of Allergy and Pediatrics at Kaleo, said in a statement.
Mylan markets EpiPen, while Pfizer manufacturers it. Supply issues started in May, but the school year has added more pressure to the situation. Amneal Pharmaceuticals, which makes the Adrenaclick, has also faced manufacturing issues this year. Pfizer also produces that drug.
The Food and Drug Administration approved a generic version of EpiPen last month. Its producer, Teva, said it would launch the drug "in the coming months" but didn't specify a date when announcing its approval.
Patients who can't fill their epinephrine prescriptions can work with Walgreens pharmacists and their doctor to see if the Auvi-Q is appropriate for them.
"Walgreens pharmacists continue to care for and work with patients and their prescribers to ensure they have access to the epinephrine auto-injectors they need, and we're pleased to work with kaléo to help meet the demand for epinephrine auto-injectors across the country," Walgreens President of Operations Richard Ashworth said in a statement.
-CNBC's Meg Tirrell contributed to this report